Windlas Biotech Limited (WINDLAS)’in fiyatı nedir?

Windlas Biotech Limited (WINDLAS)’in fiyatı $12.15’dir

Windlas Biotech Limited (WINDLAS)’in piyasa değeri nedir?

Windlas Biotech Limited (WINDLAS)’in piyasa değeri $257.09M’dir.

Windlas Biotech Limited (WINDLAS) Kazanç

Windlas Biotech Limited functions as a comprehensive contract development and manufacturing organization (CDMO). Its CDMO offerings span the full product lifecycle, encompassing initial discovery, subsequent development, licensing, and large-scale commercial production of various generic pharmaceutical and nutraceutical items. Through these services, it assists clients in bringing both established and innovative pharmaceutical and nutraceutical products to market, which are then sold under the clients' proprietary brand names. Beyond its CDMO segment, Windlas Biotech also develops and manufactures its own portfolio of domestic trade generics and over-the-counter (OTC) brands, catering to the nutritional, ayurvedic, wellness, and personal care sectors. These in-house products reach consumers via a dual distribution approach: traditional offline channels like distributors, stockists, retail pharmacies, and institutional tenders, alongside a robust online presence through various e-commerce platforms. The company's international reach extends through exports, primarily to markets such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech is headquartered in Gurugram, India.

Yıl	Kazanç	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Kazanç

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Kazanç	Kazanç Farkı	Ülke
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN
Galderma Group AG GALD.SW	-	-	CH

Şirket

Kazanç

Kazanç Farkı

Ülke